Our data revealed that LINC00941 coordinated with SOX2 to form a positive feed-forward loop to drive tumorigenesis of ESCC, thus providing a rationale to target LINC00941 as a novel therapeutic strategy. The gene discussed is SOX2; the disease is esophageal squamous cell carcinoma.